Startseite › Eierstockkrebs › Ohio › Cincinnati
Klinische Studien zu Eierstockkrebs in Cincinnati, OH
19 Studien zu Eierstockkrebs suchen Teilnehmer an Standorten in und um Cincinnati (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Teilnehmer gesuchtPhase 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Teilnehmer gesuchtPhase 2
- Site 0147 - Trihealth Cancer Institute - Harold and Eugen, Cincinnati
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Teilnehmer gesuchtPhase 2
- Research Site, Cincinnati
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- University of Cincinnati Medical Center, Cincinnati
- Oncology Hematology Care Inc, Cincinnati
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Teilnehmer gesuchtPhase 3
- University of Cincinnati Medical Center ( Site 0042), Cincinnati
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 2
- Oncology Hematology Care, Inc, Cincinnati
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 3
- St Elizabeth Healthcare, Edgewood · 8 mi entfernt
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Teilnehmer gesuchtPhase 1/2
- Christ Hospital, Cincinnati
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Teilnehmer gesuchtPhase 3
- University of Cincinnati Medical Center ( Site 0090), Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Teilnehmer gesuchtPhase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- St. Elizabeth Healthcare, Edgewood · 8 mi entfernt
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Teilnehmer gesucht
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- und 3 weitere
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- und 1 weitere
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Oncology Hematology Care Primary, Cincinnati
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Teilnehmer gesuchtPhase 2/3
- St. Elizabeth Medical Center, Edgewood · 8 mi entfernt
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
Teilnehmer gesuchtPhase 2
- St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood · 8 mi entfernt
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Teilnehmer gesuchtPhase 3
- University of Cincinnati Medical Center, Cincinnati
- TriHealth Cancer Institute - Good Samaritan Hospital, Cincinnati
- TriHealth Cancer Institute- Thomas Comprehensive Care Center, Cincinnati
- und 1 weitere
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Cincinnati
Eierstockkrebs-Studien in anderen Städten
- Houston, TX89 Studien
- New York City, NY69 Studien
- Boston, MA61 Studien
- Los Angeles, CA50 Studien
- Nashville, TN49 Studien
- Arlington, VA46 Studien
- Philadelphia, PA44 Studien
- Columbus, OH39 Studien
- St. Louis, MO38 Studien
- Chicago, IL36 Studien
- San Antonio, TX31 Studien
- Cleveland, OH30 Studien
Weitere Studien in Cincinnati
- Nichtkleinzelliges Lungenkarzinom35 Studien
- Krebs (alle Arten)27 Studien
- Brustkrebs25 Studien
- Herzinsuffizienz24 Studien
- Kolorektales Karzinom21 Studien
- Akute myeloische Leukämie20 Studien
- Metastasierender Krebs20 Studien
- Lungenkrebs19 Studien
- Adipositas19 Studien
- Prostatakrebs18 Studien
- Multiples Myelom17 Studien
- Melanom17 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.